Lihat sumber Heparin

{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 407837023
| image = Heparin General Structure V.1.svg

<!-- Clinical data -->
| pronounce = {{IPAc-en|ˈ|h|ɛ|p|ər|ɪ|n}} {{respell|HEP|ər|in}}
| tradename         =
| Drugs.com = {{drugs.com|monograph|heparin-sodium}}
| MedlinePlus       =
| DailyMedID = Heparin
| pregnancy_AU      = C
| pregnancy_AU_comment = <ref name="Heparin Interpharma APMDS">{{cite web | title=Heparin Interpharma APMDS | website=Therapeutic Goods Administration (TGA) | date=7 December 2023 | url=https://www.tga.gov.au/resources/auspmd/heparin-interpharma | access-date=7 March 2024}}</ref>
| pregnancy_category=
| routes_of_administration = [[Infus|Intravena]], [[Penyuntikan subkutan|subkutan]]
| class             =
| ATC_prefix = B01
| ATC_suffix = AB01
| ATC_supplemental = {{ATC|C05|BA03}} {{ATC|S01|XA14}}

<!-- Legal status -->
| legal_AU          = S4
| legal_AU_comment  = <ref name="Heparin Interpharma APMDS" />
| legal_BR          = <!-- OTC, A1, A2, A3, B1, B2, C1, C2, C3, C4, C5, D1, D2, E, F -->
| legal_BR_comment  =
| legal_CA          = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_CA_comment  =
| legal_DE          = <!-- Anlage I, II, III or Unscheduled -->
| legal_DE_comment  =
| legal_NZ          = <!-- Class A, B, C -->
| legal_NZ_comment  =
| legal_UK          = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM / Class A, B, C -->
| legal_UK_comment  =
| legal_US = Rx-only
| legal_US_comment  =
| legal_EU          =
| legal_EU_comment  =
| legal_UN          = <!-- N I, II, III, IV / P I, II, III, IV -->
| legal_UN_comment  =
| legal_status = Rx-only|

<!--Pharmacokinetic data-->
| bioavailability = Tak menentu
| metabolism = Hati
| elimination_half-life = 1,5 jam
| excretion = Urin<ref>{{cite web|title=Heparin|url=http://online.lexi.com |archive-url=https://web.archive.org/web/20120214182216/http://online.lexi.com/crlsql/servlet/crlonline |archive-date=14 February 2012 |date=10 February 2012|url-access=subscription}}</ref>

<!--Identifiers-->
| index2_label = sodium
| IUPHAR_ligand = 4214
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 9005-49-6
| CAS_number2_Ref = {{cascite|correct|??}}
| CAS_number2 = 9041-08-1
| PubChem = 22833565
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB01109
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 17216115
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = T2410KM04A
| KEGG = D02956
| KEGG2 = D02112
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 526514

<!--Chemical data-->
| IUPAC_name = 
| C=12 | H=19 | N=1 | O=20 | S=3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C26H41NO34S4/c1-4(28)27-7-9(30)8(29)6(2-52-63(43,44)45)53-24(7)56-15-10(31)11(32)25(58-19(15)21(36)37)55-13-5(3-62(40,41)42)14(60-64(46,47)48)26(59-22(13)38)57-16-12(33)17(61-65(49,50)51)23(39)54-18(16)20(34)35/h5-19,22-26,29-33,38-39H,2-3H2,1H3,(H,27,28)(H,34,35)(H,36,37)(H,40,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)/t5-,6+,7+,8+,9+,10+,11+,12-,13-,14+,15-,16-,17+,18+,19-,22-,23?,24+,25+,26-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = ZFGMDIBRIDKWMY-PASTXAENSA-N
}}

'''Heparin''' adalah obat [[antikoagulan]] (pengencer darah) dengan fungsi untuk mencegah pembentukan gumpalan darah.<ref>{{cite book|last=Astari|first=Rika|last2=Triana|first2=Winda|date=2018|url=http://eprints.uad.ac.id/19039/1/Kamus%20Kesehatan_11Nop18.pdf|title=Kamus Kesehatan Indonesia-Arab|place=[[Sleman]], [[Yogyakarta]]|publisher=Trussmedia Grafika|isbn=978-602-5747-22-9|edition=|pages=160|language=|coauthors=}}</ref>

Heparin digunakan untuk mengobati dan mencegah pembekuan darah di pembuluh darah, arteri, atau paru-paru. Heparin juga digunakan sebelum operasi untuk mengurangi risiko penggumpalan darah.

Injeksi Heparin tidak boleh digunakan untuk mengaliri (membersihkan) kateter intravena (IV). Produk Heparin jenis lain tersedia untuk digunakan sebagai pengunci aliran kateter.

Heparin juga dapat digunakan untuk tujuan lain yang tidak tercantum dalam panduan pengobatan ini.

== Referensi ==
[[Kategori:Heparin| ]]
[[Kategori:Glikosaminoglikan]]
[[Kategori:Obat Esensial Nasional Indonesia]]
[[Kategori:Antikoagulan]]
[[Kategori:Obat Esensial Organisasi Kesehatan Dunia]]
[[Kategori:Aldol]]
[[Kategori:Obat oftalmologi]]